7 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... HIV aged 21–29 should ... • Pap test should ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
Non-alcoholic fatty liver disease algorithm.
 
For those patients with NAFLD or liver disease of unknown aetiology,
liver disease algorithm ... Second-line tests ... Disease #NAFLD #algorithm ... #Referral #Management ... #Hepatology
Algorithm regarding the diagnosis and treatment of Hereditary Hemochromatosis HH. 

Step 1: In the patient with
Algorithm regarding ... initial screening test ... hemochromatosis #algorithm ... #diagnosis #management ... #hepatology #gastroenterology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... for Treating Mycobacterium ... empiric treatment should ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... Note: Active TB should ... AviumComplex #MAC #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Managing Microsporidiosis in HIV-AIDS
Preventing Chronic Microsporidiosis:
 • Because chronic microsporidiosis occurs
IDSA Recommendations ... immunosuppressed should ... bieneusi: • The best ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... end-organ disease is best ... CMV retinitis should ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology